1737 Stock Overview
Engages in the production and sale of salt products in Taiwan and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 2/6 |
| Financial Health | 5/6 |
| Dividends | 3/6 |
My Notes
Capture your thoughts, links and company narrative
Taiyen Biotech Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | NT$32.25 |
| 52 Week High | NT$36.35 |
| 52 Week Low | NT$31.80 |
| Beta | 0.28 |
| 1 Month Change | 0.31% |
| 3 Month Change | -9.28% |
| 1 Year Change | -5.70% |
| 3 Year Change | -2.86% |
| 5 Year Change | -0.31% |
| Change since IPO | 21.77% |
Recent News & Updates
Recent updates
Taiyen Biotech's (TWSE:1737) Dividend Will Be Reduced To NT$1.20
Jul 31
Investors Can Find Comfort In Taiyen Biotech's (TWSE:1737) Earnings Quality
May 09Taiyen Biotech (TPE:1737) Has A Pretty Healthy Balance Sheet
Apr 24Taiyen Biotech's (TPE:1737) Returns On Capital Are Heading Higher
Apr 09A Look At The Intrinsic Value Of Taiyen Biotech Co., Ltd. (TPE:1737)
Mar 25Is Taiyen Biotech Co., Ltd. (TPE:1737) Popular Amongst Institutions?
Mar 12Taiyen Biotech Co., Ltd. (TPE:1737) Stock's On A Decline: Are Poor Fundamentals The Cause?
Feb 14
Taiyen Biotech Co., Ltd. (TPE:1737) Investors Should Think About This Before Buying It For Its Dividend
Feb 01Taiyen Biotech (TPE:1737) Seems To Use Debt Quite Sensibly
Jan 17Returns On Capital - An Important Metric For Taiyen Biotech (TPE:1737)
Jan 04A Look At The Fair Value Of Taiyen Biotech Co., Ltd. (TPE:1737)
Dec 22How Much Of Taiyen Biotech Co., Ltd. (TPE:1737) Do Institutions Own?
Dec 09Shareholders Of Taiyen Biotech (TPE:1737) Must Be Happy With Their 53% Return
Nov 24Shareholder Returns
| 1737 | TW Food | TW Market | |
|---|---|---|---|
| 7D | -1.1% | -2.2% | -0.6% |
| 1Y | -5.7% | 4.9% | 28.5% |
Return vs Industry: 1737 underperformed the TW Food industry which returned 4.9% over the past year.
Return vs Market: 1737 underperformed the TW Market which returned 28.5% over the past year.
Price Volatility
| 1737 volatility | |
|---|---|
| 1737 Average Weekly Movement | 1.1% |
| Food Industry Average Movement | 2.1% |
| Market Average Movement | 4.5% |
| 10% most volatile stocks in TW Market | 7.9% |
| 10% least volatile stocks in TW Market | 2.1% |
Stable Share Price: 1737 has not had significant price volatility in the past 3 months compared to the TW market.
Volatility Over Time: 1737's weekly volatility (1%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1952 | n/a | Shi-Hui Chen | www.tybio.com.tw |
Taiyen Biotech Co., Ltd. engages in the production and sale of salt products in Taiwan and internationally. Its products portfolio includes various salt and seawater chemical products; bath salt, bath salt milk, salt soap, algae soap, and shampoo; beverage and raw drinking water; skin care; toothpaste, salt mouthwash, and eye glass care solution; salt for washing fruits and vegetables; and food and food additives. The company also manufactures western medicine, environmental pharmaceuticals, and cosmetics.
Taiyen Biotech Co., Ltd. Fundamentals Summary
| 1737 fundamental statistics | |
|---|---|
| Market cap | NT$6.45b |
| Earnings (TTM) | NT$297.63m |
| Revenue (TTM) | NT$3.22b |
21.7x
P/E Ratio2.0x
P/S RatioIs 1737 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 1737 income statement (TTM) | |
|---|---|
| Revenue | NT$3.22b |
| Cost of Revenue | NT$1.91b |
| Gross Profit | NT$1.30b |
| Other Expenses | NT$1.01b |
| Earnings | NT$297.63m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 1.49 |
| Gross Margin | 40.53% |
| Net Profit Margin | 9.24% |
| Debt/Equity Ratio | 3.0% |
How did 1737 perform over the long term?
See historical performance and comparisonDividends
3.7%
Current Dividend Yield81%
Payout RatioCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/18 21:59 |
| End of Day Share Price | 2024/12/18 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Taiyen Biotech Co., Ltd. is covered by 4 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| null null | E.Sun Securities Investment Consulting Co. Ltd. |
| Titan Horng | IBTS Investment Consulting Co., Ltd. |
| Zhennan Lee | Jih Sun Securities Investment Consulting Co., Ltd. |